BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8490906)

  • 1. Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer.
    Friberg LG; Norén H
    Cancer; 1993 Jun; 71(11):3570-4. PubMed ID: 8490906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of estrogen and progesterone receptors in endometrial carcinoma].
    Chen Y; Peng Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):98-100. PubMed ID: 12501628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis.
    Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Thorpe SM
    Int J Gynecol Pathol; 1993 Jul; 12(3):246-52. PubMed ID: 7688353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma].
    Gorchev G; Milkov V
    Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
    Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
    Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Ilić J; Babić D; Petrovecki M; Nikolić S; Marinović T; Jukić D; Vecek N
    Acta Obstet Gynecol Scand; 1994 Oct; 73(9):730-3. PubMed ID: 7976251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of estrogen and progesterone receptors in endometrial adenocarcinomas. Comparison between dextran-coated charcoal and immunoenzymatic methods on curettage biopsies.
    Marchal S; Marchal C; Hoffstetter S; Parache RM; Pernot M
    Anticancer Res; 1992; 12(4):1307-10. PubMed ID: 1380228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of hormone receptors in endometrial cancer.
    Creasman WT
    Cancer; 1993 Feb; 71(4 Suppl):1467-70. PubMed ID: 8431882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.
    Nyholm HC; Christensen IJ; Nielsen AL
    Gynecol Oncol; 1995 Dec; 59(3):347-51. PubMed ID: 8522253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
    Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
    Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
    Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
    Itoh E
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
    Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.